» Articles » PMID: 21542840

Systemic and Neurologic Autoimmune Disorders Associated with Seizures or Epilepsy

Overview
Journal Epilepsia
Specialty Neurology
Date 2011 May 6
PMID 21542840
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, we review the incidence and significance of seizures in well-established autoimmune disorders, including multiple sclerosis (MS), diabetes mellitus, celiac disease, thyroid disease, and systemic lupus erythematosus (SLE). The five following presentations discuss the incidence and possible pathogenesis of epilepsies that are found in these well-known autoimmune conditions. There is a large body of evidence describing the clinical presentation of seizures with MS and SLE, and showing that refractory epilepsy can complicate these already challenging disorders. However, the mechanisms involved are complex and generally not well understood. Neurologic syndromes, including seizure disorders, can also be a feature of celiac disease (CD) or subclinical CD, sometimes associated with cerebral calcification. The association between type-1 diabetes mellitus (T1DM) and epilepsy is unclear and requires more definitive epidemiologic analysis, despite the fact that antibodies to glutamic acid decarboxylase may provide a link between the two conditions. The association between thyroid disorders and encephalopathies, often termed Hashimoto's encephalopathy, is well known but the pathogenic significance of antithyroid antibodies in this condition is still debated. In general, the relationships between autoimmune mechanisms and seizures in these conditions are unclear; the seizures are likely to be caused by a variety of mechanisms, including ischemia, neuronal damage, and specific and nonspecific immunity.

Citing Articles

Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ....

Tien N, Wu T, Lin C, Chu F, Wang C, Hsu C Front Endocrinol (Lausanne). 2023; 14:1156952.

PMID: 37334286 PMC: 10272786. DOI: 10.3389/fendo.2023.1156952.


Epilepsy, Immunity and Neuropsychiatric Disorders.

Fortunato F, Giugno A, Sammarra I, Labate A, Gambardella A Curr Neuropharmacol. 2022; 21(8):1714-1735.

PMID: 35794773 PMC: 10514543. DOI: 10.2174/1570159X20666220706094651.


Occult Autoimmune Background for Epilepsy-The Preliminary Study on Antibodies Against Neuronal Surface Antigens.

Dziadkowiak E, Moreira H, Buska-Mach K, Szmyrka M, Budrewicz S, Barg E Front Neurol. 2021; 12:660126.

PMID: 34744955 PMC: 8567837. DOI: 10.3389/fneur.2021.660126.


Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability.

Barnes S, Zera K, Ivison G, Buckwalter M, Engleman E J Neuroinflammation. 2021; 18(1):199.

PMID: 34511110 PMC: 8436533. DOI: 10.1186/s12974-021-02262-4.


Adult-onset temporal lobe epilepsy suspicious for autoimmune pathogenesis: Autoantibody prevalence and clinical correlates.

Kuehn J, Meschede C, Helmstaedter C, Surges R, von Wrede R, Hattingen E PLoS One. 2020; 15(10):e0241289.

PMID: 33119692 PMC: 7595292. DOI: 10.1371/journal.pone.0241289.